WHITE PAPER

Single-Use Fermenters for the Production of Biologics

Currently Accepting New Projects

Our 8,000 m² facility offers a variety of equipment to suit your project’s needs including two single-use fermenters (100 L and 1,000 L), two 17,000 L fermentors, a 12,000 L refolding tank, 1.4m column chromatography capability, and UF/ DF skids from 0.5 to 120 m² scale.

If interested in learning more, complete the form below and tell us about your upcoming project. A member of our business development team will reach out as soon as possible.

© BIOVECTRA 2024. All rights reserved

SEO plus – Test

  • 20+ years at GSK, leading R&D activities on multiple vaccine programs
  • Recently held positions in industry include: Senior Director (Function Head), Protein Biochemistry; Director, Antigen Design & Prototype Production; and, Associate Director, Antigen Design and Protein Characterization.
  • Key areas of expertise are:
    • Process development of protein Biologics/Recombinant Antigens
    • Recombinant protein expression (mammalian, insect, yeast, bacterial)
    • Production/design of Viral Vectors, mRNA vaccines, Bacterial outer membrane vesicles
    • Protein Engineering and Structural Biology
    • Defining quality attributes, biophysical characterization of proteins, and analytical strategy
  • Post graduate degrees in Functional Genomics (Université Laval) and Bioinformatics (MIT); M. Sc. Microbiology and Immunology (Laval).
  • 25+ Patent & 5 Scientific Publications